DBV Technologies S.A.

ENXTPA:DBV Voorraadrapport

Marktkapitalisatie: €74.0m

DBV Technologies Beheer

Beheer criteriumcontroles 3/4

De CEO DBV Technologies is Daniel Tassé, benoemd in Nov2018, heeft een ambtstermijn van 5.67 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 2.40M, bestaande uit 25% salaris en 75% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.018% van de aandelen van het bedrijf, ter waarde € 13.15K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.2 jaar en 5.7 jaar.

Belangrijke informatie

Daniel Tassé

Algemeen directeur

US$2.4m

Totale compensatie

Percentage CEO-salaris25.0%
Dienstverband CEO6yrs
Eigendom CEO0.02%
Management gemiddelde ambtstermijn5.2yrs
Gemiddelde ambtstermijn bestuur5.7yrs

Recente managementupdates

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For DBV Technologies S.A.'s (EPA:DBV) CEO For Now

May 10
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For DBV Technologies S.A.'s (EPA:DBV) CEO For Now

Recent updates

DBV Technologies S.A.'s (EPA:DBV) 41% Share Price Surge Not Quite Adding Up

Oct 24
DBV Technologies S.A.'s (EPA:DBV) 41% Share Price Surge Not Quite Adding Up

Analysts Just Made A Major Revision To Their DBV Technologies S.A. (EPA:DBV) Revenue Forecasts

Aug 04
Analysts Just Made A Major Revision To Their DBV Technologies S.A. (EPA:DBV) Revenue Forecasts

Risks To Shareholder Returns Are Elevated At These Prices For DBV Technologies S.A. (EPA:DBV)

Jun 14
Risks To Shareholder Returns Are Elevated At These Prices For DBV Technologies S.A. (EPA:DBV)

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For DBV Technologies S.A.'s (EPA:DBV) CEO For Now

May 10
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For DBV Technologies S.A.'s (EPA:DBV) CEO For Now

DBV Technologies S.A. (EPA:DBV) Released Earnings Last Week And Analysts Lifted Their Price Target To €6.50

May 09
DBV Technologies S.A. (EPA:DBV) Released Earnings Last Week And Analysts Lifted Their Price Target To €6.50

Some DBV Technologies S.A. (EPA:DBV) Analysts Just Made A Major Cut To Next Year's Estimates

Mar 14
Some DBV Technologies S.A. (EPA:DBV) Analysts Just Made A Major Cut To Next Year's Estimates

DBV Technologies S.A. (EPA:DBV) Just Reported Earnings, And Analysts Cut Their Target Price

Mar 10
DBV Technologies S.A. (EPA:DBV) Just Reported Earnings, And Analysts Cut Their Target Price

Is DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?

Dec 01
Is DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?

Is DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?

Jun 23
Is DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?

We're Hopeful That DBV Technologies (EPA:DBV) Will Use Its Cash Wisely

Mar 09
We're Hopeful That DBV Technologies (EPA:DBV) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About DBV Technologies' (EPA:DBV) Cash Burn Situation

Oct 04
Here's Why We're Not Too Worried About DBV Technologies' (EPA:DBV) Cash Burn Situation

DBV Technologies S.A. (EPA:DBV) Shares Could Be 45% Below Their Intrinsic Value Estimate

Aug 06
DBV Technologies S.A. (EPA:DBV) Shares Could Be 45% Below Their Intrinsic Value Estimate

Here's Why DBV Technologies (EPA:DBV) Must Use Its Cash Wisely

Mar 14
Here's Why DBV Technologies (EPA:DBV) Must Use Its Cash Wisely

Will DBV Technologies (EPA:DBV) Spend Its Cash Wisely?

Oct 20
Will DBV Technologies (EPA:DBV) Spend Its Cash Wisely?

Analyse CEO-vergoeding

Hoe is Daniel Tassé's beloning veranderd ten opzichte van DBV Technologies's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-US$88m

Mar 31 2024n/an/a

-US$80m

Dec 31 2023US$2mUS$600k

-US$73m

Sep 30 2023n/an/a

-US$101m

Jun 30 2023n/an/a

-US$101m

Mar 31 2023n/an/a

-US$100m

Dec 31 2022US$3mUS$600k

-US$96m

Sep 30 2022n/an/a

-US$71m

Jun 30 2022n/an/a

-US$77m

Mar 31 2022n/an/a

-US$85m

Dec 31 2021US$2mUS$600k

-US$98m

Sep 30 2021n/an/a

-US$124m

Jun 30 2021n/an/a

-US$131m

Mar 31 2021n/an/a

-US$148m

Dec 31 2020US$2mUS$600k

-US$160m

Sep 30 2020n/an/a

-US$161m

Jun 30 2020n/an/a

-US$171m

Mar 31 2020n/an/a

-US$169m

Dec 31 2019US$3mUS$600k

-US$172m

Sep 30 2019n/an/a

-US$176m

Jun 30 2019n/an/a

-US$198m

Mar 31 2019n/an/a

-US$191m

Dec 31 2018US$5mUS$55k

-US$190m

Compensatie versus markt: De totale vergoeding ($USD 2.40M ) Daniel } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de French markt ($USD 326.18K ).

Compensatie versus inkomsten: De vergoeding van Daniel is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.


CEO

Daniel Tassé (64 yo)

6yrs

Tenure

US$2,404,486

Compensatie

Mr. Daniel Tasse had been an Independent Non-Executive Director of Indivior PLC since August 2014 until May 6, 2021 and Senior Independent Director since September 30, 2016 until May 6, 2021. Mr. Tasse ser...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Daniel Tassé
CEO & Director6yrsUS$2.40m0.018%
€ 13.1k
Virginie Simone Jeanine Boucinha
CFO & Principal Accounting Officerless than a yearUS$509.31kgeen gegevens
Pharis Mohideen
Chief Medical Officer5.3yrsUS$1.28m0.024%
€ 17.9k
Kevin Malobisky
Chief Operations Officerless than a yeargeen gegevensgeen gegevens
Katie Matthews
Investor Relations Officerno datageen gegevensgeen gegevens
Michele Robertson
Chief Legal Officer3.8yrsgeen gegevensgeen gegevens
Caroline Daniere
Chief Human Resources Officer & Chief of Staff5.2yrsgeen gegevensgeen gegevens
Wence Agbotounou
Chief Clinical Trial Officer & Senior VP8.5yrsgeen gegevensgeen gegevens
Edward Jordan
Senior Vice President of Commercial Operations North America8.8yrsgeen gegevensgeen gegevens
Alan Kerr
Senior VP & Head of Global Regulatory Affairs5.8yrsgeen gegevensgeen gegevens
Pascal Wotling
Chief External Manufacturing & Supply Chain Officerless than a yeargeen gegevensgeen gegevens
Robert Pietrusko
Chief Regulatory Officerless than a yeargeen gegevensgeen gegevens

5.2yrs

Gemiddelde duur

57.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van DBV is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.2 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Daniel Tassé
CEO & Director5.7yrsUS$2.40m0.018%
€ 13.1k
Timothy Morris
Independent Director3.7yrsUS$113.54k0.012%
€ 9.2k
Michel de Rosen
Independent Chairman of the Board6.5yrsUS$10.81k0.025%
€ 18.1k
Michael Goller
Director9.1yrsUS$113.54k0%
€ 0
Daniel Soland
Independent Director9.7yrsUS$113.54k0.026%
€ 19.2k
Mailys Ferrere
Director8.4yrsgeen gegevensgeen gegevens
Hugh Sampson
Scientific Adviser to the CEO & Chairman of Scientific Advisory Board3.9yrsgeen gegevensgeen gegevens
Paul-Henri Lambert
Member of the Scientific Advisory Boardno datageen gegevensgeen gegevens
Emma Guttman-Yassky
Member of Scientific Advisory Board5.5yrsgeen gegevensgeen gegevens
Julie O'Neill
Director7.4yrsUS$113.54k0%
€ 0
Jean-François Nicolas
Member of Scientific Advisory Board5.5yrsgeen gegevensgeen gegevens
Jim Krueger
Member of Scientific Advisory Board5.5yrsgeen gegevensgeen gegevens

5.7yrs

Gemiddelde duur

64yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van DBV wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.7 jaar).